Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

U.S. Sen. Roy Blunt: Making Medical Research a National Priority

Summary

Amazing Things Podcast: Newsmaker Edition. U.S. Senator Roy Blunt of Missouri is responsible for delivery four consecutive years of increased federal funding for biomedical research to the National Institutes of Health. Sen. Blunt, Chairman of the Senate Labor-HHS Appropriations Subcommittee, speaks candidly to Amazing Things about the promise of precision medicine and the bipartisan support behind funding America’s investment in biomedical research.

“You could save the entire defense budget for the country every single year if you could just figure out better ways to anticipate and deal with Alzheimer’s.”

U.S. Sen. Roy Blunt (R-Missouri)

“Five years ago if you talked about immunotherapy, it was, “Oh, that’s out there, but we don’t know that anybody’s really going to discover that.” We had a hearing within the last six months where it just listed on a list of things we’re doing now every day, not necessarily as research, but healthcare as if it had been around for decades. That’s how quickly I think healthcare is moving now.”

U.S. Sen. Roy Blunt (R-Missouri)

“When everything’s a priority, nothing is a priority. So we have made healthcare research a critical priority.”

U.S. Sen. Roy Blunt (R-Missouri)